Medicines and other factors causing deaths in English and welsh care homes: five-years of preventing future death reports by coroners.

Coroners preventing future death (PFD) reports care homes medicines optimisation

Journal

Journal of public health (Oxford, England)
ISSN: 1741-3850
Titre abrégé: J Public Health (Oxf)
Pays: England
ID NLM: 101188638

Informations de publication

Date de publication:
16 Dec 2023
Historique:
received: 30 01 2023
revised: 08 11 2023
medline: 18 12 2023
pubmed: 18 12 2023
entrez: 18 12 2023
Statut: aheadofprint

Résumé

Whilst information has been published on the impact, severity and causes of incidents involving medicines in care homes, it has not been systematically described. This review explored whether coroners' Preventing Future Death (PFD) reports involving medicines for people living in care homes could add to this evidence base. PFD reports made publicly available between 2017 and 2021 classified as 'care home-related deaths' were reviewed. Reports describing medicines and/or medicines processes were identified. Contributory factors within these reports were then identified. Within the timeframe, 156 reports were published, and 25 described medicines (n = 27) or medicines processes (n = 5) concerning people living in care homes. The impact of medicines and/or medicines processes was quantified as no impact (n = 7), contributory (n = 6) and direct (n = 14) per report. Two key themes emerged. Four deaths had an association between their falls risk, prescribed anticoagulants, and the failure of the service to seek timely emergency care following a fall and two deaths concerned endocrine medicines, where people refused insulin or blood sugar monitoring and staff did not seek timely advice. This study demonstrated PFD reports provide an insight into the potential association between medicines, and other aspects of the person's care in causing harm.

Sections du résumé

BACKGROUND BACKGROUND
Whilst information has been published on the impact, severity and causes of incidents involving medicines in care homes, it has not been systematically described. This review explored whether coroners' Preventing Future Death (PFD) reports involving medicines for people living in care homes could add to this evidence base.
METHODS METHODS
PFD reports made publicly available between 2017 and 2021 classified as 'care home-related deaths' were reviewed. Reports describing medicines and/or medicines processes were identified. Contributory factors within these reports were then identified.
RESULTS RESULTS
Within the timeframe, 156 reports were published, and 25 described medicines (n = 27) or medicines processes (n = 5) concerning people living in care homes. The impact of medicines and/or medicines processes was quantified as no impact (n = 7), contributory (n = 6) and direct (n = 14) per report. Two key themes emerged. Four deaths had an association between their falls risk, prescribed anticoagulants, and the failure of the service to seek timely emergency care following a fall and two deaths concerned endocrine medicines, where people refused insulin or blood sugar monitoring and staff did not seek timely advice.
CONCLUSION CONCLUSIONS
This study demonstrated PFD reports provide an insight into the potential association between medicines, and other aspects of the person's care in causing harm.

Identifiants

pubmed: 38105521
pii: 7476662
doi: 10.1093/pubmed/fdad259
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Malcolm Irons (M)

Part time PhD student, School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, Lancashire, PR1 2HE, UK.

Asa Auta (A)

Senior Lecturer, Medical School, Faculty of Health, Social Care and Medicine, Edge Hill University, Ormskirk L39 4QP, UK.

Jane Caroline Portlock (JC)

Professor Emerita Life Sciences, School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9QG, UK.

Andrea Manfrin (A)

Visiting Professor, School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, Lancashire, PR1 2HE, UK.

Classifications MeSH